Where is Pieris headquartered?

Pieris is located in Boston, MA.

Who invested in Pieris?

Pieris has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Pieris?

Pieris closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

pieris.com

Pieris

Pieris is a Massachusetts-based biotechnology company that develops and commercializes anticalin-derived drugs for the treatment of cancer and respiratory diseases.

Business Model:

Revenue: $55.3M

Employees: 51-200

Geographic Data

Address: 255 State Street

City: Boston

State: MA

Zip: 02109

Country: US

Financial Info

Stage:

grant

Raised Last:

$17M

Raised Total:

$155M

Social

Twitter

Crunchbase

Metrics

3,172,488Website Global Rank

5,084Website Monthly Traffic

Twitter Followers

Description

Pieris is a Massachusetts-based biotechnology company that develops and commercializes anticalin-derived drugs for the treatment of cancer and respiratory diseases.

Contact Phone:
+18572468998

Contact Email:

IPO Details

Pieris went public on 1/9/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
1/9/2015

Ticker Symbol:
PIRS

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2021	Grant		$17M	Bavarian Ministry of Economic Affairs
2/2018	Post-IPO Equity		$50.6M
7/2021	Post-IPO Equity		$25M
11/2019	Post-IPO Equity		$32M
11/2019	Post-IPO Equity		$0	Aquilo Capital Management EcoR1 Capital Surveyor Capital Samsara BioCapital BVF Partners BVF Partners Aquilo Capital Management EcoR1 Capital Surveyor Capital Samsara BioCapital BVF Partners BVF Partners
6/2021	Grant	1	$17.3M	Bavarian Ministry of Economic Affairs, Energy and Technology Bavarian Ministry of Economic Affairs, Energy and Technology
1/2023	Post-IPO Equity	1	$5M	Seagen Seagen
7/2015	Post-IPO Equity		$25M
12/2014	Post-IPO Equity		$0	Lombard Odier Ally Bridge Group Montrose Capital Partners OrbiMed Sphera Funds Management Lombard Odier Ally Bridge Group Montrose Capital Partners OrbiMed Sphera Funds Management
6/2016	Post-IPO Equity	1	$16.5M	Biotechnology Value Fund Biotechnology Value Fund Biotechnology Value Fund Biotechnology Value Fund
6/2016	Private Placement		$16.5M
11/2019	Post-IPO Equity	5	$32M	Aquilo Capital Management EcoR1 Capital Surveyor Capital Samsara BioCapital BVF Partners BVF Partners Aquilo Capital Management EcoR1 Capital Surveyor Capital Samsara BioCapital BVF Partners BVF Partners
12/2014	Post-IPO Equity	5	$13.6M	Ally Bridge Group Montrose Capital Partners Lombard Odier Ally Bridge Group Montrose Capital Partners Lombard Odier

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details